Pharma stocks slide as Trump’s 100% generic drug tariff plan spooks investors

Indian drug shares declined Wednesday following US President Trump’s tariff announcement. These proposed tariffs will significantly impact companies with substantial US revenue exposure. Analysts suggest investors should now focus on domestically oriented Indian pharmaceutical firms. The Nifty Pharma index saw a notable decrease, while the benchmark Nifty 50 also fell. Negotiations are expected given India’s…

Google quarterly cloud revenue growth beats expectations

Google Cloud revenue surged eighty-two percent, fueled by strong enterprise demand for AI services. This significant growth helped offset concerns regarding Alphabet’s substantial artificial intelligence investments. However, the company’s own AI model development has encountered delays this year. Google’s search business has shown strength, attracting more advertising dollars through AI features.

PRISM’s premium hotel push emerges as next leg of India growth ahead of IPO

PRISM is increasingly focusing on company-serviced and premium hospitality in India. Its company-serviced hotel network grew significantly, becoming a key business driver. These hotels contributed nearly half of India’s Gross Booking Value in nine months. This shift aligns with a broader trend in India’s fragmented hotel market. The company now emphasizes quality and productivity over…

CSB Bank Q1 profit jumps 27% YoY to Rs 150 crore as provisions decline

CSB Bank reported a twenty-seven percent year-on-year net profit increase for the June quarter. Lower provisions and improved net interest income aided the bank’s financial performance. Sequential profit declined due to typical seasonal business trends in the first quarter. Gold loans saw significant growth, while total advances also expanded. The bank focuses on customer acquisition…